Skip to main content
Lyka Labs Ltd. logo

Lyka Labs Ltd. — Investor Relations & Filings

Ticker · LYKALABS ISIN · INE933A01014 LEI · 3358001RHQJBCTT1ER45 BSE.NS Manufacturing
Open in API
Filings indexed 1,205 across all filing types
Latest filing 2024-01-24 Regulatory Filings
Country IN India
Listing BSE.NS LYKALABS

About Lyka Labs Ltd.

https://www.lykalabs.com

Lyka Labs Ltd. specializes in the development, manufacture, and marketing of pharmaceutical formulations and active pharmaceutical ingredients (APIs). The company maintains a diverse product portfolio spanning multiple therapeutic categories, including anti-infectives, dermatologicals, cardiovascular agents, and pain management. A significant area of expertise for the organization is lyophilization technology, enabling the production of high-quality injectable formulations. The company operates advanced manufacturing facilities designed to meet international quality standards, supporting its operations in both domestic and global markets. Its core activities encompass the production of various dosage forms such as tablets, capsules, ointments, and sterile injectables, with a particular focus on specialized segments like cephalosporins and critical care medications.

Recent filings

Filing Released Lang Actions
Updates
Regulatory Filings Classification · 100% confidence The document text is extremely short (519 characters) and contains only a digital signature block with no substantive content or financial data. There is no indication of a report, announcement, or detailed information. This matches the pattern of an officer certification or attestation document. According to the Certification Rule, such documents should be classified as Regulatory Filings (RNS).
2024-01-24 English
Copy of Newspaper Publication
Regulatory Filings Classification · 90% confidence The document is very short (703 characters) and contains a digital signature and a note about the publication of a Postal Ballot Notice in newspapers. There is no substantive financial data, no detailed report content, and no indication of financial results or management discussion. The document appears to be an announcement related to a voting process (Postal Ballot Notice) rather than the actual voting results or detailed meeting materials. Therefore, it is best classified as a Regulatory Filing (RNS) since it does not fit other specific categories and is an official announcement related to corporate governance procedures.
2024-01-24 English
The Company has published postal ballot notice on the newspapers
Regulatory Filings Classification · 90% confidence The document is very short (703 characters) and contains a digital signature and a note about the publication of a Postal Ballot Notice in newspapers. There is no substantive financial data, no detailed report content, and no mention of financial results or management discussion. The document appears to be an announcement related to a voting process (Postal Ballot Notice) rather than the actual voting results or detailed meeting materials. Given the brevity and nature, it is not a full report but an announcement related to shareholder voting procedures. This fits best under Regulatory Filings (RNS) as a general announcement that does not fit other specific categories.
2024-01-24 English
Loss of Share Certificates
Regulatory Filings Classification · 100% confidence The document text is extremely short (465 characters) and consists solely of a digital signature block with no substantive content, financial data, or report information. There is no indication of a report, announcement, or detailed filing. Given the nature of the content, it is most consistent with a Regulatory Filing (RNS) as a fallback category for miscellaneous filings that do not fit other specific categories.
2024-01-23 English
The company has issued duplicated share certificates as disclosed.
Regulatory Filings Classification · 100% confidence The document is extremely short (465 characters) and contains only a digital signature block with no substantive content or financial data. There is no indication of any report, announcement, or detailed information. It appears to be a certification or attestation by an officer. According to the Certification Rule, such documents should be classified as Regulatory Filings (RNS).
2024-01-23 English
Shareholders meeting
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a Notice of Postal Ballot issued by Lyka Labs Limited pursuant to Section 110 of the Companies Act, 2013. It details special business items for shareholder voting, including the appointment of an independent director and re-appointment of the managing director with remuneration details. The document includes procedural information about e-voting and references to compliance with SEBI and MCA circulars. It is not a report containing financial statements or results, nor is it a transcript or presentation. It is a formal notice to shareholders to vote on corporate governance matters. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA) or Proxy Solicitation & Information Statement (PSI). However, since this is a notice for a postal ballot (requesting votes), it aligns best with Proxy Solicitation & Information Statement (PSI), which covers materials sent to shareholders to provide information and request votes for meetings or ballots. The document is lengthy (15,000 characters) and contains detailed resolutions and voting instructions, consistent with PSI filings.
2024-01-23 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.